Q32 Bio Inc. — Form 8-K
Filed July 15, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 92/100
What the filing says
Q32 Bio Inc. (market cap ~$10.4M) executed an underwritten public offering on July 14-16, 2026, issuing 6,027,399 common shares at $18.25/share and 4,931,506 pre-funded warrants at $18.2499/warrant, with underwriters Morgan Stanley, Jefferies, Cantor Fitzgerald, and Oppenheimer. Underwriters have a 30-day option to purchase up to 1,643,835 additional shares at $17.1550/share. Gross proceeds before expenses approximately $110M from primary offering alone.
Why this rating
Massive capital raise (~10.6x company market cap) fundamentally transforms balance sheet & runway; business-changing event for micro-cap biotech.
See more from July 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.